Quarterly report · Q2
9265.TEDINET S100PWJZ
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥27.7bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥27.3bn | 2021-06-01 → 2021-11-30 | Cons. | Net sales |
| Operating income | ¥598m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Operating income | ¥663m | 2021-06-01 → 2021-11-30 | Cons. | Operating income |
| Ordinary income | ¥624m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥701m | 2021-06-01 → 2021-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥20m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥713m | 2021-06-01 → 2021-11-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥201m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥471m | 2021-06-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥204m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Net income | ¥471m | 2021-06-01 → 2021-11-30 | Cons. | Profit loss |
| Total assets | ¥22.9bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥24.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥25.1bn | at 2021-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.3bn | at 2022-11-30 | Cons. | Liabilities |
| Total liabilities | ¥16.1bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.6bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2021-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2021-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.9bn | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥581m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥751m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥88m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥27m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥318m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥209m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥229m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥229m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-78.98 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-143.68 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥184.81 | 2021-06-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.29 | 2021-09-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 33.2% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.3% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2022-11-30 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2022-11-30 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-11-30 | −¥447m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥140m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥140m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥0 |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥3m |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥27.5bn |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥27.5bn |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥11m |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥1.0bn |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥33m |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥33m |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥0 |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥27.7bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥27.7bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥11m |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2021-11-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2021-11-30 | −¥415m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥136m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥136m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥0 |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥3m |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥27.2bn |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥27.2bn |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥0 |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥34m |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥34m |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥0 |
| —segment total | revenue | 2021-06-01 → 2021-11-30 | ¥27.3bn |
| —segment total | revenue external | 2021-06-01 → 2021-11-30 | ¥27.3bn |
| —segment total | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥0 |
| —segment total | segment profit | 2021-06-01 → 2021-11-30 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 487
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E33393-000MedicalMallReportableSegmentsMember | 0 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1078000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -415000000 | JPY |
| Operating income | Prior1YTDDuration | 663000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 27488000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 140000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalMallReportableSegmentsMember | 33000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 27661000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 27661000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 11000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalMallReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 11000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -11000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 27499000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 140000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalMallReportableSegmentsMember | 33000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 27673000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -11000000 | JPY |
| Net sales | CurrentYTDDuration | 27661000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 1041000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 3000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E33393-000MedicalMallReportableSegmentsMember | 0 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1045000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -447000000 | JPY |
| Operating income | CurrentYTDDuration | 598000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)福岡財務支局長 | |
| Filing date cover page | FilingDateInstant | 2023-01-13 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第６期第２四半期(自 2022年９月１日 至 2022年11月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | YAMASHITA HEALTH CARE HOLDINGS,INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 執行役員 社長 山 下 尚 登 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)福岡市博多区下川端町２番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)092－402－2922（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 執行役員 北 野 幸 文 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)福岡市博多区下川端町２番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)092－402－2922（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 執行役員 北 野 幸 文 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E33393 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 92650 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | YAMASHITA HEALTH CARE HOLDINGS, INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |